isorders of hyperpigmentation are more common in darker-skinned individuals 1 such as the Chinese.
Results. The number of people who entered the health fair was 172, with 73 fitting the inclusion criteria (Chinese women aged 18-55 years). The total number of subjects who answered the questionnaire and were examined was 69; therefore, the participation rate was 95%. The average age of the participants was 42 years. A total of 67 of the 69 were born outside the United States, with an average age of immigration of 32 years. The 2 American-born Chinese women had their questionnaires read to them owing to their lack of Chinese reading skills, and both expressed full understanding. Most of the women were from China (70%) and Taiwan (17%), while the remaining were from Vietnam, Singapore, Cambodia, and Malaysia. The sample contained 44 and 31 cases of lentigines and PIH, respectively, but only 11 cases of melasma (Figure 2) . The question regarding self-report of lentigines had a mean (SD) sensitivity of 93.2% (3.8%) and specificity of 96.0% (3.9%). For PIH, sensitivity was 100.0%, and specificity was 92.1% (4.4%), whereas the question on melasma had a sensitivity of 81.8% (11.6%) and a specificity of 93.1% (3.3%).
Comment.
A Spanish language instrument to determine the prevalence of melasma has been developed and successfully administered to a large population of Hispanic women. 3 However, the prevalence of melasma, lentigines, and PIH is largely unknown in other populations. We at- tempted to validate a tool that can be used to determine the prevalence of hyperpigmentation disorders in Chinese women. We refined the language and syntax by consulting with Chinese teachers, and then we administered the questionnaire to a focus group to maximize comprehensibility. The results of the study in 69 female Chinese subjects show that this questionnaire is valid for selfreporting of lentigines and PIH.
Limitations include lack of a broad sample (most of the patients were middle-aged women) and the use of only 1 examiner. Reliability testing (test-retest) was not performed in this study by the subjects or the examiner. The focus of the study was to determine concordance between the subject and the examiner. Because of the low number of subjects with melasma, more Chinese women with melasma must be evaluated to determine the validity of this questionnaire for melasma. In addition, the melasma question specifically related melasma to pregnancy. This question may need to be refined, since many women develop melasma without any relation to pregnancy. The lentigines and PIH questions may be used in future studies to determine prevalence of these disorders in Chinese women. Determining the prevalence of pigmentary disorders and their impact on quality of life will assist in understanding the full impact of these disorders in various populations worldwide. 
S
everal different methods can be used to treat actinic keratoses (AKs), including cryosurgery, curettage and electrodessication, phototherapy with aminolevulinic acid, chemical peels, and various topical medications. Many topical medications either produce hypopigmentation or are irritating to the skin. 1 One would expect adherence to a treatment regimen of irritating and unpleasant topical medications to be worse than that demonstrated with a regimen of nonirritating topical agents for atopic dermatitis and psoriasis. 2 In many cases, nonadherence rather than nonresponse underlies treatment failure. 3, 4 While studies of topical 5-fluorouracil have demonstrated good efficacy for AK treatment, 5,6 few data are available on patients' compliance with therapy. Since most patients overestimate their actual use of medication, electronic monitors are more reliable assessment tools than patients' self-reports of usage. 7, 8 This study assesses patient compliance with a regimen of topical 5-fluorouracil, 0.5%, cream for the treatment of AKs by using electronic monitors hidden in the caps of the medication.
Methods. After institutional review board approval, 20 patients, 50 years or older, with moderate to severe AKs of the face and scalp were enrolled in this prospective study. Each participant was given fluorouracil, 0.5%, cream (Carac; Dermik Laboratories, Berwyn, Pennsylvania, a subsidiary of Sanofi-Aventis) with an attached Medication Event Monitoring System cap (MEMS; Aardex Corp, Geneva, Switzerland). Subjects were directed to apply the medication at bedtime each day for 4 weeks. They were assessed at baseline and at weeks 2, 4, and 8 for skin quality, local skin reaction, and number of AK 
